W
Wendy Yi Ying Wu
Researcher at Umeå University
Publications - 28
Citations - 676
Wendy Yi Ying Wu is an academic researcher from Umeå University. The author has contributed to research in topics: Breast cancer & Breast cancer screening. The author has an hindex of 10, co-authored 22 publications receiving 424 citations. Previous affiliations of Wendy Yi Ying Wu include National Taiwan University & National Yang-Ming University.
Papers
More filters
Journal ArticleDOI
Mammography screening reduces rates of advanced and fatal breast cancers: Results in 549,091 women.
Stephen W. Duffy,Laszlo Tabar,Amy Ming Fang Yen,Peter B. Dean,Robert A. Smith,Håkan Jonsson,Sven Törnberg,Sam Li Sheng Chen,Sherry Yueh Hsia Chiu,Jean Ching Yuan Fann,May Mei Sheng Ku,Wendy Yi Ying Wu,Chen Yang Hsu,Yu Ching Chen,Gunilla Svane,Edward Azavedo,Helene Grundström,Per Sundén,Karin Leifland,Ewa Frodis,Joakim Ramos,Birgitta Epstein,Anders Åkerlund,Ann Sundbom,Pál Bordás,Hans Wallin,Leena Starck,Annika Björkgren,Stina Carlson,Irma Fredriksson,Johan Ahlgren,Daniel Öhman,Lars Holmberg,Tony Hsiu Hsi Chen +33 more
TL;DR: It is of paramount importance to evaluate the impact of participation in organized mammography service screening independently from changes in breast cancer treatment, which can be done by measuring the incidence of fatal breast cancer.
Journal ArticleDOI
The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening.
Laszlo Tabar,Peter B. Dean,Tony Hsiu Hsi Chen,Amy Ming Fang Yen,Sam Li Sheng Chen,Jean Ching Yuan Fann,Sherry Yueh Hsia Chiu,May Mei Sheng Ku,Wendy Yi Ying Wu,Chen Yang Hsu,Yu Ching Chen,Kerri Beckmann,Robert A. Smith,Stephen W. Duffy +13 more
TL;DR: Women and their health care providers need a reliable answer to this important question: If a woman chooses to participate in regular mammography screening, then how much will this choice improve her chances of avoiding a death from breast cancer compared with women who choose not to participate.
Journal ArticleDOI
Insights from the Breast Cancer Screening Trials: How Screening Affects the Natural History of Breast Cancer and Implications for Evaluating Service Screening Programs
Laszlo Tabar,Amy Ming Fang Yen,Wendy Yi Ying Wu,Sam Li Sheng Chen,Sherry Yueh Hsia Chiu,Jean Ching Yuan Fann,May Mei Sheng Ku,Robert A. Smith,Stephen W. Duffy,Tony Hsiu Hsi Chen +9 more
TL;DR: Evidence is provided that the average mortality reduction in all the trials underestimates the true mortality reduction, and that substantially greater breast cancer mortality reductions can be expected in screening programs that are effective in reducing advanced stage breast cancer.
Journal ArticleDOI
Long-term incidence of breast cancer by trial arm in one county of the Swedish Two-County Trial of mammographic screening.
Amy Ming Fang Yen,Stephen W. Duffy,Tony Hsiu Hsi Chen,Li Sheng Chen,Sherry Yueh Hsia Chiu,Jean Ching Yuan Fann,Wendy Yi Ying Wu,Chiu Wen Su,Robert A. Smith,Laszlo Tabar +9 more
TL;DR: This study estimated the excess incidence (overdiagnosis) of breast cancer associated with starting mammographic screening at an earlier age, by using data from the Dalarna County component of the Swedish Two‐County Trial of Breast cancer screening.
Journal ArticleDOI
Metabolic phenotypes of obesity: frequency, correlates and change over time in a cohort of postmenopausal women.
Geoffrey C. Kabat,Wendy Yi Ying Wu,Wendy Yi Ying Wu,Jennifer W. Bea,Chu Chen,Lihong Qi,Marcia L. Stefanick,Rowan T. Chlebowski,D. S. Lane,Jean Wactawski-Wende,Sylvia Wassertheil-Smoller,T E Rohan +11 more
TL;DR: Over the 6 years of follow-up, one-third of women with the healthy obese phenotype transitioned to the metabolically unhealthy obese (MUO) phenotype and there was a marked tendency toward increased metabolic deterioration with increasing BMI and toward metabolic improvement with lower BMI.